India Pharmaceutical Market Projected to Reach USD 76.7 Billion by 2024

New York, USA, 2018-Jul-31 — /EPR Network/ —The Latest Research Report Published by Goldstein Research on India Pharmaceutical Market reflect that the market size is set to cross USD 76.7 billion by 2024, growing at a CAGR of 15.9% over the forecast period 2016-2024.

A new trend is witnessed among the players of an industry that they are using inorganic growth as a key growth strategy. More deals are expected to happen in Indian companies acquiring assets in US/Europe, rather than MNCs acquiring Indian companies. India pharmaceutical market segmentation has been done on the basis of type and geography.

India has become the third largest global generic API merchant market by 2016, with a 7.2% market share and the India pharmaceutical industry accounts for the second largest number of Abbreviated New Drug Applications (ANDAs). India pharmaceutical market, by players, the highest expenditure based on research and development is done by Sun Pharma (USD 352 Million), followed by Dr. Reddy (USD 199 million). Further, Cipla formed an exclusive partnership with Serum Institute of India to sell vaccines in South Africa.

Download Exclusive Sample Report: https://www.goldsteinresearch.com/request-sample/india-pharmaceutical-market-industry-overview

Market Segmentation

On the basis of our in-depth analysis, India Pharmaceutical Market can be segmented as follows:

By Type

• Active Pharmaceutical Ingredients (APIs)

1. Branded
2. Generics

• Contract Research and Manufacturing Services
• Formulations (CRAMS)

1. Chronic
2. Cardiovascular
3. Anti-Diabetes
4. Gastro-Intestinal
5. Neurological
6. Acute
7. Anti-infectives
8. Respiratory
9. Pain
10. Gynecology

• Biosimilars

Browse Full Report: https://www.goldsteinresearch.com/report/india-pharmaceutical-market-industry-overview

“India Pharmaceutical Market Outlook 2024” contains a detailed overview of the India pharmaceutical market. On the basis of our in-depth analysis, the market can be segmented in terms of market segmentation by type & geography.

Further, for the in-depth analysis, India Pharmaceutical Market Report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis.

This market research report also includes a competitive overview of some of the major key players of companies such as Sun Pharma, Dr.Reddy, Lupin, Cipla, Aurobindo, Candila. Glenmark, Torrent Pharma, Alkem Lab, Divis Lab, Piramal Enter, Ipca Lab, Glaxo SmithKline, Abbott India, Biocon, Jubilant life, Sanofi India, Wockhardt, Pfizer, Dr Lal Path Lab, Merck, Hikal, Novartis India, Eris Life, etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.

Overall, the report represents the India pharmaceutical market trends along with a market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market essential strategies & plan according to the current and expected emerging trends in the future.

Browse Similar Report: https://www.goldsteinresearch.com/report/singapore-pharmaceutical-market-outlook-2024-opportunity-assessment-and-demand-analysis-market-forecast-2016-2024